1. Home
  2. BNR vs RETO Comparison

BNR vs RETO Comparison

Compare BNR & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • RETO
  • Stock Information
  • Founded
  • BNR 2014
  • RETO 1999
  • Country
  • BNR China
  • RETO China
  • Employees
  • BNR N/A
  • RETO N/A
  • Industry
  • BNR Medical Specialities
  • RETO Multi-Sector Companies
  • Sector
  • BNR Health Care
  • RETO Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • RETO Nasdaq
  • Market Cap
  • BNR 29.1M
  • RETO 24.7M
  • IPO Year
  • BNR 2020
  • RETO 2017
  • Fundamental
  • Price
  • BNR $3.66
  • RETO $3.19
  • Analyst Decision
  • BNR
  • RETO
  • Analyst Count
  • BNR 0
  • RETO 0
  • Target Price
  • BNR N/A
  • RETO N/A
  • AVG Volume (30 Days)
  • BNR 38.6K
  • RETO 31.2K
  • Earning Date
  • BNR 06-06-2025
  • RETO 06-30-2025
  • Dividend Yield
  • BNR N/A
  • RETO N/A
  • EPS Growth
  • BNR N/A
  • RETO N/A
  • EPS
  • BNR N/A
  • RETO N/A
  • Revenue
  • BNR $72,112,038.00
  • RETO $1,828,976.00
  • Revenue This Year
  • BNR $136.32
  • RETO N/A
  • Revenue Next Year
  • BNR N/A
  • RETO N/A
  • P/E Ratio
  • BNR N/A
  • RETO N/A
  • Revenue Growth
  • BNR 0.53
  • RETO N/A
  • 52 Week Low
  • BNR $2.18
  • RETO $2.86
  • 52 Week High
  • BNR $7.90
  • RETO $18.20
  • Technical
  • Relative Strength Index (RSI)
  • BNR 58.05
  • RETO 43.77
  • Support Level
  • BNR $3.38
  • RETO $3.05
  • Resistance Level
  • BNR $4.19
  • RETO $3.63
  • Average True Range (ATR)
  • BNR 0.41
  • RETO 0.21
  • MACD
  • BNR 0.07
  • RETO -0.03
  • Stochastic Oscillator
  • BNR 61.87
  • RETO 36.25

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: